Larvol Delta - Carisma-Therapeutics-Announces-FDA-Clearance-of-IND-Application-for-CT0525-a-Novel-HER2Targeting-CARMonocyte

CT-0525 - CARISMA Therap

https://www.prnewswire.com/news-releases/carisma-therapeutics-announces-fda-clearance-of-ind-application-for-ct-0525-a-novel-her2-targeting-car-monocyte-301998422.html

Nov 28, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next